1101Usefulness of fibroblast growth factor 23 and soluble suppression of tumorigenicity 2 as predictors of poor outcome in heart failure with preserved ejection fraction

Authors :: Clotilde Roy
C. De Meester
David Vancraeynest
B. Gerber
Christophe Beauloye
S. Horman
Damien Gruson
Agnes Pasquet
A Ginion
Jean-Louis Vanoverschelde
Alisson Slimani
Mihaela Silvia Amzulescu
B Ferracin
A.C. Pouleur
Source :: European Heart Journal. 39
Publication Year :: 2018
Publisher :: Oxford University Press (OUP), 2018.

Subjects :: Fibroblast growth factor 23
medicine.medical_specialty
business.industry
Internal medicine
Cardiology
medicine
Cardiology and Cardiovascular Medicine
business
Heart failure with preserved ejection fraction

Full Text Access

Tools